Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 21, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	149,361	175,818	159,100	-	-	-
Market Cap Growth	-23.30%	10.51%	-	-	-	-
Enterprise Value	146,057	173,015	157,079	-	-	-
Last Close Price	1427.70	1669.95	1502.75	-	-	-
PE Ratio	46.22	47.31	51.64	-	-	-
Forward PE	33.38	41.55	43.46	-	-	-
PS Ratio	13.27	14.65	15.65	-	-	-
PB Ratio	8.18	9.70	10.42	-	-	-
P/TBV Ratio	8.18	9.71	10.42	-	-	-
P/FCF Ratio	115.18	131.85	88.50	-	-	-
P/OCF Ratio	61.08	71.90	59.93	-	-	-
PEG Ratio	1.76	1.66	1.43	-	-	-
EV/Sales Ratio	12.98	14.42	15.45	-	-	-
EV/EBITDA Ratio	32.42	33.74	35.82	-	-	-
EV/EBIT Ratio	37.80	37.60	40.62	-	-	-
EV/FCF Ratio	112.63	129.75	87.37	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.09
Debt / EBITDA Ratio	0.00	0.01	0.02	0.09	0.22	0.27
Debt / FCF Ratio	0.01	0.02	0.05	0.31	1.19	-
Asset Turnover	0.59	0.64	0.63	0.60	0.57	0.58
Inventory Turnover	1.53	1.93	1.66	0.94	0.99	0.88
Quick Ratio	4.70	4.77	4.58	2.43	2.71	3.92
Current Ratio	6.97	6.17	6.31	3.79	4.08	5.74
Return on Equity (ROE)	18.93%	22.26%	21.88%	20.06%	16.64%	26.55%
Return on Assets (ROA)	12.62%	15.40%	15.04%	13.26%	11.47%	17.80%
Return on Capital (ROIC)	13.97%	17.16%	16.91%	15.07%	12.70%	19.78%
Return on Capital Employed (ROCE)	20.50%	24.90%	24.80%	22.70%	19.80%	28.10%
Earnings Yield	2.17%	2.11%	1.94%	-	-	-
FCF Yield	0.87%	0.76%	1.13%	-	-	-
Dividend Yield	0.75%	0.64%	0.58%	-	-	-
Payout Ratio	34.55%	24.63%	23.19%	22.31%	40.31%	2.43%
Total Shareholder Return	0.48%	0.64%	0.58%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.